ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,663, issued on July 29, was assigned to ADICET THERAPEUTICS INC. (Redwood City, Calif.).
"Engineered GammaDelta T-cells" was invented by Aya Jakobovits (Beverly Hills, Calif.), Orit Foord (Foster City, Calif.), Andy An-deh Lin (Palo Alto, Calif.) and Marianne Theresa Santaguida (Belmont, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to engineered GammaDelta T-cell(s) and methods for using the same as a therapeutic with a potent and selective ability to target an antigen of choice. Engineered GammaDelta T-cells of the disclosure are useful in the treatment of various cancers, infectious diseases, and immune disor...